Literature DB >> 18663658

Controversies surrounding the categorization of fungal sinusitis.

Arunaloke Chakrabarti1, Ashim Das, Naresh K Panda.   

Abstract

Though rhinosinusitis is a common disorder, controversies surround the categorization of chronic rhinosinusitis (CRS) and the role of fungus in CRS. The diagnosis of each category is important for optimum therapy and predicting the course. Based on histopathological findings, fungal rhinosinusitis (FRS) can be broadly divided into two categories: the invasive and non-invasive depending on invasion of the mucosal layer. Three types of FRS are tissue-invasive: acute invasive, chronic invasive, & granulomatous. The two non-invasive FRS disorders are fungal ball, and fungus related eosinophilic rhinosinusitis including allergic fungal rhinosinusitis (AFRS). The distinction of granulomatous from chronic invasive type is not beyond controversy as both types have a chronic course and predominant orbital involvement. Maximum confusion surrounds the entity of fungus-related eosinophilic rhinosinusitis, and the definition of AFRS. In the diagnosis of AFRS, the detection of fungi in allergic mucin is considered important, although hyphae are sparse in sinus content. This leads to confusion in definition of this entity, especially with the description of two more closely related entities--eosinophilic fungal rhinosinusitis (EFRS) and eosinophilic mucin rhinosinusitis (EMRS). Recently reports of histologic invasion in possible cases of AFRS were also documented. Currently, there are more questions than answers concerning the categorization of FRS.

Entities:  

Mesh:

Year:  2008        PMID: 18663658     DOI: 10.1080/13693780802213357

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  15 in total

1.  Chronic invasive sinus aspergillosis in immunocompetent hosts: a geographic comparison.

Authors:  Brandon J Webb; Holenarasipur R Vikram
Journal:  Mycopathologia       Date:  2010-06-23       Impact factor: 2.574

2.  Analysis of fungal ball rhinosinusitis by culturing fungal clumps under endoscopic surgery.

Authors:  Junyi Zhang; Yunchuan Li; Xinxin Lu; Xiangdong Wang; Hongrui Zang; Tong Wang; Bing Zhou; Luo Zhang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 3.  Fungal Rhinosinusitis: Unravelling the Disease Spectrum.

Authors:  Virendra Singh
Journal:  J Maxillofac Oral Surg       Date:  2019-01-28

Review 4.  Pathology of Fungal Rhinosinusitis: A Review.

Authors:  Kathleen T Montone
Journal:  Head Neck Pathol       Date:  2016-02-01

Review 5.  Fungal disease of the nose and sinuses: an updated overview.

Authors:  Christopher Chang; M Eric Gershwin; George R Thompson
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

6.  Prevalence of fungal infection among Iranian patients with chronic sinusitis.

Authors:  B Naghibzadeh; E Razmpa; Sh Alavi; M Emami; M Shidfar; Gh Naghibzadeh; A Morteza
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-02       Impact factor: 2.124

7.  An unusual phaeoid fungi: Ulocladium, as a cause of chronic allergic fungal sinusitis.

Authors:  R Kaur; A Wadhwa; A Gulati; Ak Agrawal
Journal:  Iran J Microbiol       Date:  2010-06

8.  Fungal rhinosinusitis: a retrospective microbiologic and pathologic review of 400 patients at a single university medical center.

Authors:  Kathleen T Montone; Virginia A Livolsi; Michael D Feldman; James Palmer; Alexander G Chiu; Donald C Lanza; David W Kennedy; Laurie A Loevner; Irving Nachamkin
Journal:  Int J Otolaryngol       Date:  2012-02-08

9.  The aftermath of COVID-19 pandemic: Rhino-orbital mucormycosis.

Authors:  Suhas Ashok Hooli; Vaijayanti Nitin Gadre; Sunita Bage; Manoj Dnyanba Gilvarkar
Journal:  Indian J Anaesth       Date:  2021-07-23

10.  Efficacy of a marine bacterial nuclease against biofilm forming microorganisms isolated from chronic rhinosinusitis.

Authors:  Robert C Shields; Norehan Mokhtar; Michael Ford; Michael J Hall; J Grant Burgess; Mohamed Reda ElBadawey; Nicholas S Jakubovics
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.